Reply to "Comment on: Pathological features of 11,337 patients with primary ductal carcinoma in situ (DCIS) and subsequent events: results from the UK Sloane Project"
Br J Cancer
.
2021 Apr;124(8):1463-1464.
doi: 10.1038/s41416-021-01281-5.
Epub 2021 Feb 16.
Authors
Abeer M Shaaban
1
,
Bridget Hilton
2
,
Karen Clements
2
,
Sarah E Pinder
3
,
Alastair M Thompson
4
Affiliations
1
Queen Elizabeth Hospital Birmingham and University of Birmingham, Birmingham, UK. abeer.shaaban@uhb.nhs.uk.
2
Screening Quality Assurance Service, Public Health England, London, UK.
3
School of Cancer & Pharmaceutical Sciences, King's College London and Guy's and St Thomas' Hospitals NHS Foundation Trust, Birmingham, UK.
4
Baylor College of Medicine, Houston, TX, USA.
PMID:
33589775
PMCID:
PMC8039026
DOI:
10.1038/s41416-021-01281-5
No abstract available
Publication types
Letter
Comment
MeSH terms
Carcinoma, Intraductal, Noninfiltrating* / epidemiology
Carcinoma, Intraductal, Noninfiltrating* / surgery
Humans
Mammography
Mastectomy, Segmental
United Kingdom / epidemiology